$FTHM
Fathom Holdings Inc. Stock $fthm

$fthm Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000141057822000318 Filed on March 09, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$95.46M	$330.2M	$53.41M
YoY Change	78.73%	86.8%	60.92%
Cost Of Revenue	$87.81M	$306.0M	$50.45M
YoY Change	74.05%	83.88%	57.36%
Gross Profit	$7.655M	$24.25M	$2.960M
YoY Change	158.61%	133.18%	161.95%
Gross Profit Margin	8.02%	7.34%	5.54%
Selling, General & Admin	$7.935M	$34.63M	$4.270M
YoY Change	85.83%	206.82%	74.29%
% of Gross Profit	103.66%	142.79%	144.26%
Research & Development	$3.911M	$3.911M	$400.0K
YoY Change	877.75%	951.34%
% of Gross Profit	51.09%	16.13%	13.51%
Depreciation & Amortization	$970.0K	$2.748M	$60.00K
YoY Change	1516.67%	1565.45%	200.0%
% of Gross Profit	12.67%	11.33%	2.03%
Operating Expenses	$11.89M	$346.3M	$4.270M
YoY Change	178.34%	94.51%	74.29%
Operating Profit	-$4.230M	-$16.11M	-$1.310M
YoY Change	222.9%	1163.14%	-0.76%
Interest Expense	-$4.000K	$7.000K	$0.00
YoY Change		-91.67%	-100.0%
% of Operating Profit
Other Income/Expense, Net	-$125.0K	$367.0K	$0.00
YoY Change		-595.95%
Pretax Income	-$4.053M	-$15.74M	-$1.320M
YoY Change	207.05%	1066.64%	-2.22%
Income Tax	-$427.0K	-$3.247M	-$40.00K
% Of Pretax Income
Net Earnings	-$3.626M	-$12.49M	-$1.270M
YoY Change	185.51%	831.47%	-5.93%
Net Earnings / Revenue	-3.8%	-3.78%	-2.38%
Basic Earnings Per Share		-$0.88
Diluted Earnings Per Share	-$238.1K	-$0.88	-$94.42K
COMMON SHARES
Basic Shares Outstanding	14.80M	14.27M
Diluted Shares Outstanding		14.27M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.83M	$37.83M	$28.58M
YoY Change	32.37%	32.37%	4827.59%
Cash & Equivalents	$37.80M	$37.83M	$28.60M
Short-Term Investments
Other Short-Term Assets	$12.64M	$12.64M	$2.230M
YoY Change	466.77%	466.77%	443.9%
Inventory
Prepaid Expenses
Receivables	$3.981M	$3.981M	$1.595M
Other Receivables	$0.00	$0.00	$170.0K
Total Short-Term Assets	$54.45M	$54.45M	$32.86M
YoY Change	65.72%	65.7%	1891.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.250M	$5.603M	$155.0K
YoY Change	706.45%	849.66%	-58.11%
Goodwill	$20.54M		$799.0K
YoY Change	2470.84%
Intangibles	$24.24M		$922.0K
YoY Change	2529.39%
Long-Term Investments
YoY Change
Other Assets	$93.00K	$93.00K	$56.00K
YoY Change	66.07%	55.0%
Total Long-Term Assets	$50.48M	$50.48M	$2.369M
YoY Change	2030.86%	2038.98%	182.02%
TOTAL ASSETS
Total Short-Term Assets	$54.45M	$54.45M	$32.86M
Total Long-Term Assets	$50.48M	$50.48M	$2.369M
Total Assets	$104.9M	$104.9M	$35.23M
YoY Change	197.89%	197.93%	1314.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.303M	$5.303M	$2.596M
YoY Change	104.28%	103.96%	182.17%
Accrued Expenses	$4.491M	$4.725M	$1.065M
YoY Change	321.69%	483.33%	-29.47%
Deferred Revenue
YoY Change
Short-Term Debt	$9.577M	$9.577M	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$831.0K	$831.0K	$256.0K
YoY Change	224.61%	219.62%	1180.0%
Total Short-Term Liabilities	$21.07M	$21.07M	$4.990M
YoY Change	322.28%	322.28%	69.73%
LONG-TERM LIABILITIES
Long-Term Debt	$146.0K	$146.0K	$283.0K
YoY Change	-48.41%	-47.86%	-47.59%
Other Long-Term Liabilities	$3.562M	$3.562M	$300.0K
YoY Change	1087.33%	1087.33%	66.67%
Total Long-Term Liabilities	$146.0K	$3.708M	$283.0K
YoY Change	-48.41%	539.31%	-60.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.07M	$21.07M	$4.990M
Total Long-Term Liabilities	$146.0K	$3.708M	$283.0K
Total Liabilities	$24.78M	$24.78M	$5.574M
YoY Change	344.56%	344.88%	52.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.98M		-$7.488M
YoY Change	166.81%
Common Stock	$0.00		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$30.00K		$30.00K
YoY Change	0.0%
Treasury Stock Shares	$5.683M		$5.683M
Shareholders Equity	$80.15M	$80.15M	$29.65M
YoY Change
Total Liabilities & Shareholders Equity	$104.9M	$104.9M	$35.23M
YoY Change	197.89%	197.93%	1314.66%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$3.626M	-$12.49M	-$1.270M
YoY Change	185.51%	831.47%	-5.93%
Depreciation, Depletion And Amortization	$970.0K	$2.748M	$60.00K
YoY Change	1516.67%	1565.45%	200.0%
Cash From Operating Activities	-$5.126M	-$11.70M	-$880.0K
YoY Change	482.5%	861.92%	3.53%
INVESTING ACTIVITIES
Capital Expenditures	-$886.0K	$877.0K	-$370.0K
YoY Change	139.46%	1228.79%	208.33%
Acquisitions		$11.08M
YoY Change		4211.67%
Other Investing Activities	-$112.0K	-$11.08M	-$170.0K
YoY Change	-34.12%	6418.24%
Cash From Investing Activities	-$998.0K	-$14.56M	-$540.0K
YoY Change	84.81%	1500.0%	350.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$80.00K
YoY Change		-250.94%
Debt Paid & Issued, Net		$740.0K
YoY Change		4252.94%
Cash From Financing Activities	31.72M	34.62M	0.000
YoY Change		11.28%	-100.0%
NET CHANGE
Cash From Operating Activities	-5.126M	-11.70M	-880.0K
Cash From Investing Activities	-998.0K	-14.56M	-540.0K
Cash From Financing Activities	31.72M	34.62M	0.000
Net Change In Cash	25.60M	8.359M	-1.420M
YoY Change	-1902.75%	-71.16%	195.83%
FREE CASH FLOW
Cash From Operating Activities	-$5.126M	-$11.70M	-$880.0K
Capital Expenditures	-$886.0K	$877.0K	-$370.0K
Free Cash Flow	-$4.240M	-$12.57M	-$510.0K
YoY Change	731.37%	880.81%	-30.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Common Stock Value CommonStockValue
CY2020Q4	us-gaap	Common Stock Value CommonStockValue
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14269078
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11404262
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14269078
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11404262
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16751606
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12491000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1341000
CY2021	us-gaap	Lessee Operating Lease Existence Of Residual Value Guarantee LesseeOperatingLeaseExistenceOfResidualValueGuarantee	false
CY2021	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13830351
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001753162
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39412
CY2021	dei	Entity Registrant Name EntityRegistrantName	FATHOM HOLDINGS INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NC
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-1518164
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	2000 Regency Parkway Drive
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Cary
CY2020Q4	us-gaap	Assets Assets	35225000
CY2020	dei	Auditor Location AuditorLocation	Raleigh, North Carolina
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37830000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28577000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	91000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	984000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3981000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1595000
CY2021Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	53000
CY2021Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	9862000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2633000
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27518
CY2021	dei	City Area Code CityAreaCode	888
CY2021	dei	Local Phone Number LocalPhoneNumber	455-6040
CY2021	dei	Security12b Title Security12bTitle	Common Stock, No Par Value
CY2021	dei	Trading Symbol TradingSymbol	FTHM
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	169317461
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17019076
CY2021	dei	Auditor Firm AuditorFirmId	34
CY2020	dei	Auditor Firm AuditorFirmId	243
CY2021	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2021	dei	Auditor Location AuditorLocation	Raleigh, North Carolina
CY2020	dei	Auditor Name AuditorName	BDO USA, LLP
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1700000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	54450000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	32856000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1250000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	155000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4353000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	437000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24243000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	922000
CY2021Q4	us-gaap	Goodwill Goodwill	20541000
CY2020Q4	us-gaap	Goodwill Goodwill	799000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	93000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	56000
CY2021Q4	us-gaap	Assets Assets	104930000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5303000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2596000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4401000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1065000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	90000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	933000
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9577000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	831000
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	256000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	870000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	140000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21072000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4990000
CY2021Q4	fthm	Long Term Debt Excluding Current Maturities And Notes Payable LongTermDebtExcludingCurrentMaturitiesAndNotesPayable	146000
CY2020Q4	fthm	Long Term Debt Excluding Current Maturities And Notes Payable LongTermDebtExcludingCurrentMaturitiesAndNotesPayable	283000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3562000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	301000
CY2021Q4	us-gaap	Liabilities Liabilities	24780000
CY2020Q4	us-gaap	Liabilities Liabilities	5574000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16751606
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13830351
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5683000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5683000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	30000
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	30000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100159000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37169000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19979000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7488000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	80150000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	29651000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104930000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35225000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	330230000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	176784000
CY2021	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	300509000
CY2020	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	166344000
CY2021	fthm	Operations And Support Expense OperationsAndSupportExpense	5470000
CY2020	fthm	Operations And Support Expense OperationsAndSupportExpense	21000
CY2021	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	3911000
CY2020	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	372000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32733000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10316000
CY2021	us-gaap	Marketing Expense MarketingExpense	1895000
CY2020	us-gaap	Marketing Expense MarketingExpense	970000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1817000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36000
CY2021	us-gaap	Operating Expenses OperatingExpenses	346335000
CY2020	us-gaap	Operating Expenses OperatingExpenses	178059000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-16105000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-1275000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	433000
CY2021	us-gaap	Interest Expense InterestExpense	7000
CY2020	us-gaap	Interest Expense InterestExpense	84000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-59000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	367000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-74000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15738000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1349000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3247000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12491000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1341000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14269078
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11404262
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-1158000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	83000
CY2020	fthm	Stock Issued During Period Value Public Offering StockIssuedDuringPeriodValuePublicOffering	34300000
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	252000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3183000
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	30000
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	728000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1341000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	29651000
CY2021	fthm	Stock Issued During Period Value Public Offering StockIssuedDuringPeriodValuePublicOffering	35000000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2471000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	25538000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	80000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4843000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12491000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	80150000
CY2021	us-gaap	Profit Loss ProfitLoss	-12491000
CY2020	us-gaap	Profit Loss ProfitLoss	-1341000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2748000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	165000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	433000
CY2021	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	5205000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4011000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	728000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3339000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-46000
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	248000
CY2020	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	133000
CY2020	fthm	Non Cash Lease Expense NonCashLeaseExpense	-21000
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	15000
CY2021	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	179297000
CY2021	fthm	Increase Decrease Proceeds From Sale Of Mortgage Loans Held For Sales IncreaseDecreaseProceedsFromSaleOfMortgageLoansHeldForSales	182786000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1254000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1263000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1248000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	879000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1674000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1468000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1112000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-736000
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1001000
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	608000
CY2021	fthm	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-675000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-584000
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	23000
CY2021	fthm	Increase Decrease In Other Noncurrent Asset IncreaseDecreaseInOtherNoncurrentAsset	31000
CY2020	fthm	Increase Decrease In Other Noncurrent Asset IncreaseDecreaseInOtherNoncurrentAsset	55000
CY2021	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-37000
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-120000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11697000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1216000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	877000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11081000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	257000
CY2020	fthm	Payments To Acquisition Related Costs Through Issuance Of Loan Receivable PaymentsToAcquisitionRelatedCostsThroughIssuanceOfLoanReceivable	165000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2602000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	422000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14560000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-910000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	740000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	17000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	80000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	83000
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1129000
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1618000
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	35000000
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	34300000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2471000
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3183000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	30000
CY2020	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-500000
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	454000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	34616000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31107000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	8360000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Significant Risks and Business Uncertainties</i> — The Company is subject to the risks and challenges associated with companies at a similar stage of development. These include dependence on key individuals, successful development and marketing of its offerings, and competition with larger companies with greater financial, technical, and marketing resources. Furthermore, during the period required to achieve substantially higher revenue in order to become consistently profitable, the Company may require additional funds that might not be readily available or might not be on terms that are acceptable to the Company.</p>
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	28982000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29561000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	579000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37921000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29561000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	13000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	88000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	39000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23000
CY2021	fthm	Capitalized Share Based Compensation Expense CapitalizedShareBasedCompensationExpense	833000
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1839000
CY2020	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	160000
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	25538000
CY2020	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	252000
CY2020	us-gaap	Stock Issued1 StockIssued1	678000
CY2021	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	433000
CY2021	fthm	Loan Receivable Forgiven And Used As Purchase Consideration LoanReceivableForgivenAndUsedAsPurchaseConsideration	165000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37830000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28577000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	91000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	984000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37921000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29561000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37800000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28600000
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</i> — The preparation of consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates its estimates and assumptions related to provisions for doubtful accounts, legal contingencies, income taxes, deferred tax asset valuation allowances, share-based compensation, goodwill, estimated lives of intangible assets, and intangible asset impairment. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company might differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2021Q4	fthm	Agent Annual Fees Receivable Net AgentAnnualFeesReceivableNet	200000
CY2021	fthm	Agent Fees AgentFees	500
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</i> - Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation with no effect on the previously reported net (loss) income or stockholders’ equity. Subsequent to the acquisitions of LiveBy and E4:9, the Company made a change to its segment reporting structure as more fully described in Note 18. This resulted in new line items on the consolidated statement of operations for the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Gross commission income is comprised of revenues from the Real Estate Brokerage segment which were previously recorded in revenue.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other revenue is comprised of revenues not included in the Real Estate Brokerage segment which were previously recorded in revenue.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Commission and other agent-related costs is comprised of the direct costs to fulfill the services from the Real Estate Brokerage segment which were previously recorded in cost of revenue.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Operations and support are comprised of the direct costs to fulfill the services not included in the Real Estate Brokerage segment which were previously recorded in cost of revenue.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Technology and development expenses primarily include personnel costs, including base pay, bonuses, benefits, and share based compensation, related to ongoing development and maintenance of our proprietary software for use by our agents, customers, and support staff. Technology and development expenses also include data licenses, other software, and equipment costs, as well as infrastructure and operational expenses, such as, for data centers, communication, and hosted services, which were previously recorded in general and administrative. Amortization of capitalized software and website development costs which were previously recorded in depreciation and amortization expense are now recorded to technology and development expense.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Depreciation and amortization represent the depreciation charged on the Company’s fixed assets and intangible assets which were previously recorded in general and administrative expenses. As noted above, these costs exclude amortization of capitalized software and website development costs which are recorded to technology and development expense.</span></td></tr></table><div style="margin-top:12pt;"/>
CY2020Q4	us-gaap	Goodwill Goodwill	799000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	19742000
CY2021Q4	us-gaap	Goodwill Goodwill	20541000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1497000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	306000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	247000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	151000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1250000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	155000
CY2021	us-gaap	Depreciation Depreciation	200000
CY2020	us-gaap	Depreciation Depreciation	100000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	26983000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2740000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24243000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1087000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	165000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	922000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	4020000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	3920000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	3806000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	3571000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	2987000
CY2021Q4	fthm	Finite Lived Intangible Assets Amortization Expense Rolling After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour	5939000
CY2021Q4	fthm	Finite Lived Intangible Assets Amortization Expense Due FiniteLivedIntangibleAssetsAmortizationExpenseDue	24243000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	43996
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.46
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	510
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	20156
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.71
CY2021Q4	fthm	Deferred Annual Fees Current DeferredAnnualFeesCurrent	546000
CY2020Q4	fthm	Deferred Annual Fees Current DeferredAnnualFeesCurrent	293000
CY2021Q4	fthm	Due To Sellers DueToSellers	1400000
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1033000
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	202000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1422000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	570000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4401000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1065000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	977000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	539000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	146000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	283000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.03
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1326
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13638
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	44.00
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16974
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.71
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4.71352
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4.71352
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4.71352
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	37130
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.71
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y4M24D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	21164
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10202
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.10
CY2020	fthm	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	47332
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y6M
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	443
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.64
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.84
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4011000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	97000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	800000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	11700000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	240100
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.00
CY2020Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	677082
CY2020	fthm	Class Of Warrant Or Right Outstanding Granted ClassOfWarrantOrRightOutstandingGranted	240100
CY2020	fthm	Class Of Warrant Or Right Granted Weighted Average Exercise Price ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice	11.00
CY2020	fthm	Class Of Warrant Or Right Granted Remaining Contractual Term ClassOfWarrantOrRightGrantedRemainingContractualTerm	P5Y
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	240100
CY2020Q4	fthm	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	11.00
CY2020	fthm	Class Of Warrant Or Right Outstanding Remaining Contractual Term ClassOfWarrantOrRightOutstandingRemainingContractualTerm	P4Y7M2D
CY2020Q4	fthm	Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue	6012104
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	968000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	168000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	388000
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	66000
CY2021	us-gaap	Lease Cost LeaseCost	1356000
CY2020	us-gaap	Lease Cost LeaseCost	234000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4353000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	437000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4353000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	437000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	870000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	140000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3562000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	301000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4432000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	441000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y11M23D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M13D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0591
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0767
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1119000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1047000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	968000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	847000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1131000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5112000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	680000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4432000
CY2020	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	500000
CY2021	us-gaap	Related Party Costs RelatedPartyCosts	500000
CY2020	us-gaap	Related Party Costs RelatedPartyCosts	200000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12491000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1341000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14269078
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11404262
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-92000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-38000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-92000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-38000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2983000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-38000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-356000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-8000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3339000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-46000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3247000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3305000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-284000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-200000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.01
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	200
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	203000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.01
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	272000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.20
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	55000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4000
CY2020	fthm	Income Tax Reconciliation Return To Provision Adjustments IncomeTaxReconciliationReturnToProvisionAdjustments	-700
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	600
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3247000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.21
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.01
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0063
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5581000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2103000
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	6000
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	39000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	47000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	15000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	713000
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	43000
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	53000
CY2021Q4	fthm	Deferred Tax Assets Tax Credit Carry Forwards Research And Development DeferredTaxAssetsTaxCreditCarryForwardsResearchAndDevelopment	35000
CY2021Q4	fthm	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1009000
CY2020Q4	fthm	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	101000
CY2021Q4	fthm	Deferred Tax Asset Basis In Partnership DeferredTaxAssetBasisInPartnership	3000
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	16000
CY2020Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	5000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7447000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2244000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	66000
CY2021Q4	fthm	Deferred Tax Liabilities Intangibles DeferredTaxLiabilitiesIntangibles	3432000
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	877000
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	173000
CY2020Q4	fthm	Deferred Tax Liabilities Stock Compensation DeferredTaxLiabilitiesStockCompensation	126000
CY2021Q4	fthm	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	991000
CY2020Q4	fthm	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	100000
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	229000
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	198000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5595000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	596000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1852000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1648000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	330230000
CY2021	fthm	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	-8159000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2748000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	367000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3247000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4011000
CY2021	fthm	Transaction Related Costs TransactionRelatedCosts	1187000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12491000
CY2021Q4	fthm	Assets Held In Escrow AssetsHeldInEscrow	2300000

Files In Submission

Name	View Source	Status
0001410578-22-000318-index-headers.html	Edgar Link	pending
0001410578-22-000318-index.html	Edgar Link	pending
0001410578-22-000318.txt	Edgar Link	pending
0001410578-22-000318-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
fthm-20211231.xsd	Edgar Link	pending
fthm-20211231x10k.htm	Edgar Link	pending
fthm-20211231x10k001.jpg	Edgar Link	pending
fthm-20211231x10k002.jpg	Edgar Link	pending
fthm-20211231x10k_htm.xml	Edgar Link	completed
fthm-20211231xex21d1.htm	Edgar Link	pending
fthm-20211231xex23d1.htm	Edgar Link	pending
fthm-20211231xex23d2.htm	Edgar Link	pending
fthm-20211231xex31d1.htm	Edgar Link	pending
fthm-20211231xex31d2.htm	Edgar Link	pending
fthm-20211231xex32d1.htm	Edgar Link	pending
fthm-20211231_cal.xml	Edgar Link	unprocessable
fthm-20211231_def.xml	Edgar Link	unprocessable
fthm-20211231_lab.xml	Edgar Link	unprocessable
fthm-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FTHM
Fathom Holdings Inc. Stock $fthm

2021 Q4 Form 10-K Financial Statement

#000141057822000318 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTHM Fathom Holdings Inc. Stock $fthm

2021 Q4 Form 10-K Financial Statement

#000141057822000318 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTHM
Fathom Holdings Inc. Stock $fthm